When Mr Lim Wee Kiat was studying at Nanyang Technological University, he decided to impress a fellow student he had a crush on in an unusual way – by signing up as a bone marrow donor at a booth set ...
A phase 2 clinical trial has demonstrated that pomalidomide, used to treat bone marrow cancer, is safe and effective for managing hereditary hemorrhagic telangiectasia, a rare genetic bleeding ...